Kochi firm PNB Vesper Life completes Phase 2 clinical trial of COVID-19 drug
The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support
PTI | February 22, 2021 | Updated 17:13 IST
The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency use.
The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support.
After Corona vaccine now the expectation of getting covid 19 medicine Know More
jagran.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagran.com Daily Mail and Mail on Sunday newspapers.
Kochi Firm Pnb Vesper Life Completes Second Phase Clinical Trial Of Covid Drug - कोच्चि की कंपनी ने बनाई कोरोना की दवा, जल्द मांगेगी आपातकालीन इस्तेमाल की इजाजत
amarujala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from amarujala.com Daily Mail and Mail on Sunday newspapers.